This paper is in the following e-collection/theme issue:

Theme Issue 2017: Improving Global and National Responses to the HIV Epidemic Through High Quality HIV Surveillance Data (15) HIV/AIDS/STI Prevention and Care (726)

Published on in Vol 3 , No 4 (2017) :Oct-Dec

Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers

Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers

Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers

Authors of this article:

Yvan Hutin 1 Author Orcid Image ;   Daniel Low-Beer 1 Author Orcid Image ;   Isabel Bergeri 1 Author Orcid Image ;   Sarah Hess 1 Author Orcid Image ;   Jesus Maria Garcia-Calleja 1 Author Orcid Image ;   Chika Hayashi 1 Author Orcid Image ;   Antons Mozalevskis 2 Author Orcid Image ;   Annemarie Rinder Stengaard 2 Author Orcid Image ;   Keith Sabin 3 Author Orcid Image ;   Hande Harmanci 1 Author Orcid Image ;   Marc Bulterys 1 Author Orcid Image
Article Authors Cited by (17) Tweetations (25) Metrics

Journals

  1. Nguyen M, Wong G, Gane E, Kao J, Dusheiko G. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clinical Microbiology Reviews 2020;33(2) View
  2. Behzadifar M, Gorji H, Rezapour A, Bragazzi N. The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon’s multiple streams framework. Health Research Policy and Systems 2019;17(1) View
  3. Reiser M, Wiebner B, Hirsch J. Neural-network analysis of socio-medical data to identify predictors of undiagnosed hepatitis C virus infections in Germany (DETECT). Journal of Translational Medicine 2019;17(1) View
  4. Cheng C, Feng C, Chua C. Help-Seeking Experiences of Hepatitis B Patients in Transnational Medical Care: The Solution to Health Inequality Is Social Mobility. Healthcare 2019;7(4):125 View
  5. Mårdh O, Quinten C, Amato-Gauci A, Duffell E. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA – descriptive analysis and estimation of 2015 baseline. Infectious Diseases 2020;52(9):625 View
  6. Rice B, Sanchez T, Baral S, Mee P, Sabin K, Garcia-Calleja J, Hargreaves J. Know Your Epidemic, Strengthen Your Response: Developing a New HIV Surveillance Architecture to Guide HIV Resource Allocation and Target Decisions. JMIR Public Health and Surveillance 2018;4(1):e18 View
  7. Pedrana A, Howell J, Scott N, Schroeder S, Kuschel C, Lazarus J, Atun R, Baptista-Leite R, 't Hoen E, Hutchinson S, Aufegger L, Peck R, Sohn A, Swan T, Thursz M, Lesi O, Sharma M, Thwaites J, Wilson D, Hellard M. Global hepatitis C elimination: an investment framework. The Lancet Gastroenterology & Hepatology 2020;5(10):927 View
  8. Behzadifar M, Gorji H, Rezapour A, Bragazzi N. Comparison of prevention, screening and treatment of hepatitis C in Iran, Egypt and Georgia. Journal of Virus Eradication 2019;5(2):116 View
  9. Applegate T, Fajardo E, Sacks J. Hepatitis C Virus Diagnosis and the Holy Grail. Infectious Disease Clinics of North America 2018;32(2):425 View
  10. Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on global epidemiology of viral hepatitis and preventive strategies. World Journal of Clinical Cases 2018;6(13):589 View
  11. Howell J, Pedrana A, Schroeder S, Scott N, Aufegger L, Atun R, Baptista-Leite R, Hirnschall G, ‘t Hoen E, Hutchinson S, Lazarus J, Olufunmilayo L, Peck R, Sharma M, Sohn A, Thompson A, Thursz M, Wilson D, Hellard M. A global investment framework for the elimination of hepatitis B. Journal of Hepatology 2021;74(3):535 View
  12. Al Awaidy S, Ezzikouri S. Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action. Journal of Infection and Public Health 2020;13(2):221 View
  13. Li M, Wang Z, Zhang L, Zheng H, Zhou M, Liu D. Burden of viral hepatitis caused by specific aetiologies in China, 1990–2016: findings from the GBD 2016. BMC Public Health 2020;20(1) View
  14. Duffell E, Cortez‐Pinto H, Simonova M, Dalgard O, Dahl E, de Martel C, Mozalevskis A, Buti M, Pavlova S, Hadzhilova T, Simões C, Katzarov K, Mardh O. Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C. Journal of Viral Hepatitis 2021;28(8):1177 View
  15. Alberts C, Clifford G, Georges D, Negro F, Lesi O, Hutin Y, de Martel C. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. The Lancet Gastroenterology & Hepatology 2022;7(8):724 View
  16. Flores E, Howell J. Bridging the gap to achieve viral hepatitis mortality targets. The Lancet Gastroenterology & Hepatology 2022;7(8):691 View

Books/Policy Documents

  1. Nath Chatterjee A, Al Basir F. Mathematical Analysis of Infectious Diseases. View